======= ANKRD33 ======= == Gene Information == * **Official Symbol**: ANKRD33 * **Official Name**: ankyrin repeat domain 33 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=341405|341405]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z3H0|Q7Z3H0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANKRD33&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANKRD33|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620857|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a transcriptional repressor for CRX-activated photoreceptor gene regulation. {ECO:0000250|UniProtKB:Q8BXP5}. |Ank| |Ank 2| |negative regulation of transcription regulatory region DNA binding| |skeletal muscle cell differentiation| |regulation of transcription regulatory region DNA binding| |negative regulation of DNA binding| |skeletal muscle tissue development| |regulation of DNA binding| |skeletal muscle organ development| |negative regulation of binding| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |regulation of binding| |muscle structure development| |negative regulation of transcription by RNA polymerase II| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| |tissue development| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp90|WYE-354 6μM R02 exp90]]|-2.08| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|-1.73| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|1.96| |[[:results:exp145|PNU96415E 10μM R03 exp145]]|1.99| |[[:results:exp210|LB-100 2μM R05 exp210]]|2.14| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13458 * **Expression level (log2 read counts)**: -3.08 {{:chemogenomics:nalm6 dist.png?nolink |}}